Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 347.55MEnterprise Value
VS
Market
Sector
Industry
History
$ 4.99Close
$ 0.84 - $ 5.94 52-Week Range
Ticker Information
Ticker
GALTCompany Name
GALECTIN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGALECTIN THERAPEUTICS INC - Enterprise Value Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GALT - EV Historical data
| Date | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
|---|---|---|---|---|
| 6/30/2025 | $ 13.77M | $ 120.46M | $ 347.55M | $ 240.87M |
| 3/31/2025 | $ 7.43M | $ 107.92M | $ 184.03M | $ 83.54M |
| 12/31/2024 | $ 15.12M | $ 106.23M | $ 168.19M | $ 77.08M |
| 9/30/2024 | $ 27.06M | $ 104.55M | $ 250.09M | $ 172.6M |
| 6/30/2024 | $ 25.6M | $ 93.42M | $ 207.95M | $ 140.13M |
| 3/31/2024 | $ 23.55M | $ 82.46M | $ 249.08M | $ 190.17M |
| 12/31/2023 | $ 25.66M | $ 71.74M | $ 194.03M | $ 147.95M |
| 9/30/2023 | $ 20.36M | $ 61.14M | $ 161.38M | $ 120.6M |
| 6/30/2023 | $ 17.97M | $ 60.36M | $ 131.17M | $ 88.78M |
| 3/31/2023 | $ 17.8M | $ 49.94M | $ 129.86M | $ 97.71M |
Key Performance Insights, Last 5 Years
- GALECTIN THERAPEUTICS INC's latest trailing twelve months (TTM) EV stands at $ 111.28M.
- Over the past 5 years, GALECTIN THERAPEUTICS INC's average EV has been $ 166.19M.
- The median EV for GALECTIN THERAPEUTICS INC during this period was $ 156.9M
- GALECTIN THERAPEUTICS INC reached its highest EV over the past 5 years at $ 347.55M.
- The lowest EV recorded by GALECTIN THERAPEUTICS INC in the same timeframe $ 72.5M
Similar metrics to Market Cap:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Enterprise Value
[Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].Market Cap + Debt - CashnEq
(=) EV EV for GALECTIN THERAPEUTICS INC is calculated as follows: Market Cap [ $ 143.83M ] + Debt [ $ 0 ] - CashnEq [ $ 32.56M ]
(=) EV [ $ 111.28M ] GALT - Enterprise Value, Last 5 years
$ 72.5M
Minimum
Mar 31, 2022
$ 347.55M
Maximum
Jun 30, 2025
$ 166.19M
Average
$ 156.9M
Median
EV Benchmark AnalysisMarket
The chart above depicts the distribution of EV for companies in the Total Stock Market. The average EV of the companies is $ 1.25B with a standard deviation of $ 1.66B.
The following table provides additional summary stats:
EV in the Market:
| filtered constituents | 3.33K |
|---|---|
| min | $ -1.69B |
| max | $ 6.81B |
| average | $ 1.25B |
| median | $ 438.06M |
| std | $ 1.66B |